Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Determinants of renal flow reserve in adult patients with and without renal artery stenosis.

Physiological reports·2025

Same author

The prediction of alterations in plasma sodium levels in acutely ill patients should be more comprehensive. Author's reply.

European journal of internal medicine·2024

Same author

Prediction of plasma sodium changes in the acutely ill patients: the potential role of tissue sodium content.

European journal of internal medicine·2024

Same author

Do cool shirts make a difference? The effects of upper body garments on health, fluid balance and performance during exercise in the heat.

BMC sports science, medicine & rehabilitation·2023

Same author

Autonomic regulation in different hypertensive phenotypes - the HELIUS study.

Blood pressure·2023

Same author

Southern ocean carbon and heat impact on climate.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2023

Search research articles

Related Experiment Videos

Model-based decision support in diabetes care.

E Salzsieder¹, L Vogt, K-D Kohnert

¹Institute of Diabetes "Gerhardt Katsch" Karlsburg, Greifswalder Str. 11e, D-17495 Karlsburg, Germany. salzsied@diabetes-karlsburg.de

Computer Methods and Programs in Biomedicine

|July 13, 2010

Summary

This summary is machine-generated.

The Karlsburg Diabetes Management System (KADIS®) improves diabetes care by providing physicians with evidence-based recommendations. This patient-focused tool optimizes metabolic control through personalized, in silico simulations and clinical trials.

Related Experiment Videos

Area of Science:

Medical Informatics
Endocrinology
Clinical Decision Support

Background:

Diabetes management requires continuous optimization of metabolic control.
Physicians need effective tools for individualized patient care.
Existing systems may lack personalized, evidence-based decision support.

Purpose of the Study:

To develop and evaluate the Karlsburg Diabetes Management System (KADIS®) as a decision-support tool.
To assess KADIS®'s effectiveness in optimizing metabolic control for diabetes patients.
To validate the system's utility in routine clinical practice.

Main Methods:

Development of a model-based, patient-focused decision-support system (KADIS®).
Implementation of personalized, in silico simulation procedures.
Evaluation through open-label trials, a case-control study, and routine clinical application.

Main Results:

KADIS® recommendations significantly improved metabolic control in diabetes patients.
The system demonstrated effectiveness in guiding personalized treatment decisions.
Successful integration and application in routine diabetes outpatient care.

Conclusions:

The model-based KADIS® system effectively supports physicians in optimizing diabetes care.
Personalized, evidence-based recommendations enhance metabolic control.
KADIS® is a valuable tool for individualized diabetes management.